CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4

J Korbecki, K Kojder, D Simińska… - International journal of …, 2020 - mdpi.com
CC chemokines, a subfamily of 27 chemotactic cytokines, are a component of intercellular
communication, which is crucial for the functioning of the tumor microenvironment. Although …

Aptamers: potential diagnostic and therapeutic agents for blood diseases

MM Aljohani, D Cialla-May, J Popp, R Chinnappan… - Molecules, 2022 - mdpi.com
Aptamers are RNA/DNA oligonucleotide molecules that specifically bind to a targeted
complementary molecule. As potential recognition elements with promising diagnostic and …

[HTML][HTML] Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia

M Goswami, G Gui, LW Dillon, KE Lindblad… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background The powerful 'graft versus leukemia'effect thought partly responsible for the
therapeutic effect of allogeneic hematopoietic cell transplantation in acute myeloid leukemia …

The cytokine network in acute myeloid leukemia

M Luciano, PW Krenn, J Horejs-Hoeck - Frontiers in immunology, 2022 - frontiersin.org
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone
marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid …

Macrophages in acute myeloid leukaemia: Significant players in therapy resistance and patient outcomes

KE Miari, ML Guzman, H Wheadon… - Frontiers in cell and …, 2021 - frontiersin.org
Acute Myeloid Leukaemia (AML) is a commonly occurring severe haematological
malignancy, with most patients exhibiting sub-optimal clinical outcomes. Therapy resistance …

Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance

KE Miari, MTS Williams - British Journal of Pharmacology, 2024 - Wiley Online Library
The bone marrow (BM) is the primary site of adult haematopoiesis, where stromal elements
(eg fibroblasts and mesenchymal stem cells [MSCs]) work in concert to support blood cell …

The role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 ligands in molecular cancer processes and clinical aspects of acute myeloid leukemia (AML)

J Korbecki, P Kupnicka, K Barczak, M Bosiacki… - Cancers, 2023 - mdpi.com
Simple Summary AML is a type of leukemia with a very unfavorable prognosis. Some of the
new therapeutic targets that are being investigated by researchers worldwide are …

[HTML][HTML] Secretome analysis using Affinity Proteomics and Immunoassays: a focus on Tumor Biology

VM Beutgen, V Shinkevich, J Pörschke… - Molecular & Cellular …, 2024 - Elsevier
The study of the cellular secretome using proteomic techniques continues to capture the
attention of the research community across a broad range of topics in biomedical research …

Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia

YD Irani, CH Kok, J Clarson… - Blood …, 2023 - ashpublications.org
Dysregulation of immune-checkpoint receptors has been reported at diagnosis of chronic
myeloid leukemia (CML), however, their role in the maintenance of remission after tyrosine …

Acute myeloid leukemia: from biology to clinical practices through development and pre-clinical therapeutics

X Roussel, E Daguindau, A Berceanu… - Frontiers in …, 2020 - frontiersin.org
Recent studies have provided several insights into acute myeloid leukemia. Studies based
on molecular biology have identified eight functional mutations involved in leukemogenesis …